当前位置: X-MOL 学术Am. J. Public Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prior Authorization Requirements and Medicaid Enrollees' Use of Tobacco Cessation Medications, Colorado, 2023.
American Journal of Public Health ( IF 9.6 ) Pub Date : 2024-10-24 , DOI: 10.2105/ajph.2024.307868
Marcus Dillender,Robin Mermelstein

Despite tobacco cessation medications being a first-line treatment for quitting smoking, a majority of Medicaid programs require health care providers to obtain prior authorization before prescribing them. We examined the impact of Colorado's Medicaid program removing its prior authorization requirement for these drugs on their use and estimated the additional number of Coloradoans who used these therapies in 2023 because of the policy change. The findings indicate that these requirements decrease low-income people's use of these medications. (Am J Public Health. Published online ahead of print October 24, 2024:e1-e5. https://doi.org/10.2105/AJPH.2024.307868).

中文翻译:


事先授权要求和医疗补助参保者使用戒烟药物,科罗拉多州,2023 年。



尽管戒烟药物是戒烟的一线治疗方法,但大多数 Medicaid 计划要求医疗保健提供者在开具处方前获得事先授权。我们研究了科罗拉多州的医疗补助计划取消对这些药物的事先授权要求对其使用的影响,并估计了由于政策变化而在 2023 年使用这些疗法的科罗拉多州人的额外人数。研究结果表明,这些要求减少了低收入人群对这些药物的使用。(美国公共卫生杂志。2024 年 10 月 24 日提前在线发布:e1-e5。https://doi.org/10.2105/AJPH.2024.307868)。
更新日期:2024-10-24
down
wechat
bug